Labetalol in resistant hypertension

Area of Science:

• Pharmacology
• Cardiovascular Medicine

Background:

• Severe hypertension poses significant risks, including target organ damage.
• Inadequate control of blood pressure on existing therapies necessitates alternative treatment strategies.

Purpose of the Study:

• To evaluate the efficacy of labetalol in managing severe hypertension.
• To assess the required dosage and side effects of labetalol in this patient group.

Main Methods:

• A study involving 16 patients with severe hypertension (supine diastolic blood pressure >110 mmHg).
• Labetalol was added to existing antihypertensive regimens, which were then gradually withdrawn.
• Patients were hospitalized for therapy adjustments.

Main Results:

• Satisfactory blood pressure control was achieved in 10 out of 16 patients.
• High mean daily doses of labetalol (3,091 mg) were required.
• Treatment was discontinued in 6 patients due to postural hypotension, uncontrolled blood pressure, or urinary retention.

Conclusions:

• Labetalol can be effective in severe hypertension, but often requires high doses.
• Potential side effects, such as postural hypotension, must be monitored.
• Long-term treatment appeared relatively free from adverse effects in this study.